ADVERTISEMENT



Google       
Call (866) 635-2689 for a free Personal Injury evaluation by attorney in your area.

Home -> Law Blog Directory -> Personal Injury Law Blogs -> A Georgia Lawyer

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Personal Injury Law

: A Georgia Lawyer

Preemption Before U.S. Supreme Court

ADVERTISEMENTS
A good piece on the WSJ Law Blog regarding the Levine v. Wyeth case, which is front and center on the preemption issue.

Preemption simply stated is the position that FDA approval of a drug supercedes state law claims challenging safety, efficacy, or labeling. Drugmakers and the FDA argue preemption exists by maintaining the agency?s actions are the final word on safety and effectiveness. The court?s decision, therefore, is being closely watched because its ruling will determine whether patients can sue a drugmaker through state law when a product has already been approved by the FDA.


In part from the WSJ Blog:

"At the center of the case is the delivery technique for an antihistamine called Phenergan. Diana Levine, the plaintiff, sought treatment for nausea. Clinicians administered Phenergan using a delivery technique called ?IV push,? as opposed to ?IV drip.? As a result, Levine, a guitar player, developed gangrene in her arm, which eventually required its amputation. Both Wyeth and the FDA were aware that the ?IV push? risked inadvertent arterial injection and gangrene, but the FDA nevertheless approved labeling for Phenergan that warned against ? but did not prohibit ? IV push administration. (For more background, go to Scotus blog.) Superior court in Vermont had instructed a jury that the label?s compliance with FDA regulations did not establish its adequacy when considering Wyeth?s negligance. The jury awarded Levine more than $6 million in damages. "

Go here for more.

From various sources, it looks like the justices took issue with Wyeth?s argument that it couldn?t update its label to add stronger warnings without first getting FDA approval. ?Wyeth could have gone back to the FDA anytime? to update the label, Justice David Souter said. ?And it simply didn?t do it.? Source.


You can also read the transcript of the argument here.

Full post as published by A Georgia Lawyer on November 04, 2008 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Lawsuits and Settlements

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0131 secs (new cache)